# Bioimpedance Analysis in Chronic Heart Failure

Study · id `cardio:ct-nct02662439` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02662439](<https://clinicaltrials.gov/study/NCT02662439>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02662439

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 240 participants.

## Technical summary

Registry record NCT02662439. Randomized; no masking; primary purpose diagnostic. Start 2016-02 (registry gives no type); primary completion 2018-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 240 participants (planned count; ClinicalTrials.gov record NCT02662439, source copy `cardio:ctgov-nct02662439-2017-06-01`, retrieved 2026-10-26)
- Start date: 2016-02 (registry gives no type) (ClinicalTrials.gov record NCT02662439, source copy `cardio:ctgov-nct02662439-2017-06-01`, retrieved 2026-10-26)
- Primary completion: 2018-12 (anticipated) (ClinicalTrials.gov record NCT02662439, source copy `cardio:ctgov-nct02662439-2017-06-01`, retrieved 2026-10-26)
- Completion: Not reported
- Countries: Hungary (ClinicalTrials.gov record NCT02662439, source copy `cardio:ctgov-nct02662439-2017-06-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "SUSPENDED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02662439-2017-06-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Bioimpedance Analysis in Chronic Heart Failure
- Condition: Heart Failure
- Intervention (Device): Body Composition Monitor (BCM)
- Lead sponsor: Peter Studinger
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)

## Provenance

Content hash: e0871045f4575821d608b8f6674b371be81cd3ef761ae3058f3ffe286bcc7e95
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
